Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
1,893,544
-
Share change
-
+1,297,118
-
Total reported value
-
$351,167,088
-
Price per share
-
$185.40
-
Number of holders
-
132
-
Value change
-
+$240,877,855
-
Number of buys
-
62
-
Number of sells
-
38
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2023
As of 31 Dec 2023,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,893,544 shares.
The largest 10 holders included
Fisher Asset Management, LLC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, ENVESTNET ASSET MANAGEMENT INC, RiverFront Investment Group, LLC, RAYMOND JAMES & ASSOCIATES, Tower Research Capital LLC (TRC), ROYAL BANK OF CANADA, BROWN ADVISORY INC, and CITADEL ADVISORS LLC.
This page lists
137
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.